Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.9% sodium chloride----5件: 6, 14, 51, 53, 65 💬
210% liquid formulation OF human immunoglobulin----1件: 14 💬
3ACT-HIB----3件: 14, 62, 222 💬
4ANTI-C5 antibody----4件: 11, 14, 62, 109 💬
5ANTI-thymocyte globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬
6ARGX-113----5件: 11, 14, 35, 53, 63 💬
7ARGX-117----1件: 14 💬
8ARGX-117 IV----1件: 14 💬
9Autologous hematopoietic stem cell transplantation----7件: 11, 13, 14, 28, 49, 51, 84 💬
10Batoclimab1件: Batoclimab1件: Batoclimab 💬 --2件: 11, 14 💬
11Batoclimab 340 MG SC weekly1件: Batoclimab1件: Batoclimab 💬 --2件: 11, 14 💬
12Batoclimab 680 milligrams (MG) subcutaneous (SC) weekly1件: Batoclimab1件: Batoclimab 💬 --1件: 14 💬
13BIVV020----2件: 14, 61 💬
14Carmustine1件: Carmustine1件: Carmustine 💬 --5件: 11, 13, 14, 28, 60 💬
15Clorfenamina maleato1件: Chlorpheniramine2件: Chlorpheniramine maleate ,
Chlorphenamine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 14 💬
16Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
17Cytarabine1件: Cytarabine2件: Cytarabine ,
Cytarabine hydrochloride 💬 		--7件: 11, 13, 14, 25, 34, 49, 60 💬
18Dexamethasone1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 19, 28, 35, 63, 64, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
19DNTH103----2件: 11, 14 💬
20Eculizumab1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬8件: 11, 13, 14, 61, 62, 109, 221, 222 💬
21Efgartigimod----6件: 11, 14, 35, 53, 63, 64 💬
22Efgartigimod alfa1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --6件: 11, 14, 35, 53, 63, 162 💬
23Efgartigimod PH20 SC----5件: 11, 14, 35, 63, 162 💬
24Efgartigimod PH20 SC IN stage B----1件: 14 💬
25Empasiprubart1件: Empasiprubart1件: Empasiprubart 💬 1件: C2 💬 6件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 14 💬
26Etoposide1件: Etoposide2件: Etoposide ,
Etoposide phosphate 💬 		--12件: 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
27Fampridine1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14 💬
28Fampyra1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14 💬
29Fibrinogen concentrate1件: Fibrinogen human1件: Fibrinogen I 125 💬 --1件: 14 💬
30Fingolimod1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156 💬
31Fingolimod hydrochloride1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
32Fresh frozen plasma----2件: 5, 14 💬
33FTY720I----1件: 14 💬
34Gammanorm----2件: 14, 65 💬
35Gilenya1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 2, 13, 14 💬
36Gilenya 0,5 MG Cápsulas duras1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 14 💬
37Group C meningococcal conjugate vaccine----1件: 14 💬
38H.P. acthar® GEL----1件: 14 💬
39HB-admscs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---7件: 2, 4, 6, 13, 14, 46, 49 💬
40HBM9161----1件: 14 💬
41Hematopoietic stem cell transplantation----13件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
42Hidrocloruro DE fingolimod1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
43Hizentra1件: Human immunoglobulin G1件: Globulin, immune 💬 --4件: 14, 50, 51, 65 💬
44HL161BKN----1件: 14 💬
45Human immunoglobulin G1件: Human immunoglobulin G1件: Globulin, immune 💬 --3件: 14, 50, 63 💬
46Human normal immunoglobulin1件: Human immunoglobulin G1件: Globulin, immune 💬 --8件: 11, 13, 14, 43, 45, 50, 63, 65 💬
47Human normal immunoglobulin FOR intravenous administration1件: Human immunoglobulin G1件: Globulin, immune 💬 --3件: 14, 51, 65 💬
48Hyqvia1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 14, 65 💬
49I10----1件: 14 💬
50I10E----3件: 14, 63, 65 💬
51Igpro10----4件: 14, 51, 63, 65 💬
52Igpro20----4件: 14, 50, 51, 65 💬
53Igvena*FL 200ML 10G+SET----2件: 14, 50 💬
54Immune globulin----3件: 11, 13, 14 💬
55Immune globulin (human) 10% solution FOR intravenous administration----1件: 14 💬
56Immune globulin 10% intravenous solution----1件: 14 💬
57Immune globulin IV (human), 10% caprylate/chromatography purified----1件: 14 💬
58Immunoadsorption----2件: 13, 14 💬
59Immunoglobulin----3件: 13, 14, 63 💬
60Immunoglobulin G----9件: 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
61Immunoglobulin perfusion----1件: 14 💬
62Immunoglobulina umana normale PER somministrazione endovenosa----1件: 14 💬
63Immunoglobuline G----1件: 14 💬
64Immunoglobulins----1件: 14 💬
65IMVT-1401----2件: 11, 14 💬
66Intratect----4件: 13, 14, 35, 65 💬
67Intravenous immune globulin G----1件: 14 💬
68Intravenous immunoglobulin----8件: 13, 14, 35, 38, 39, 49, 51, 309 💬
69Iqymune----1件: 14 💬
70Ivig----8件: 11, 13, 14, 35, 51, 63, 65, 172 💬
71Kiovig1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 14, 65 💬
72Kiovig 100 MG/ML solution FOR infusion1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 14, 65 💬
73Laboratory biomarker analysis----22件: 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
74Lipoic acid1件: Lipoic acid1件: Thioctic acid 💬 --3件: 13, 14, 20 💬
75M281/JNJ-80202135----1件: 14 💬
76Mabthera - 1 fiala 500 MG 50 ML1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 14 💬
77MD1003----5件: 2, 10, 13, 14, 20 💬
78Melphalan1件: Melphalan2件: Melphalan ,
Melphalan hydrochloride 💬 		--19件: 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
79Menjugate----1件: 14 💬
80Methylprednisolon1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 14, 51, 66 💬
81Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
82Metilprednisolone sodio succinato----4件: 13, 14, 56, 66 💬
83N. meningitidis group C polysaccharide----1件: 14 💬
84Newgam----3件: 14, 63, 65 💬
85Nipocalimab1件: Nipocalimab1件: Nipocalimab 💬 --6件: 11, 14, 46, 49, 53, 61 💬
86NPB-01----3件: 13, 14, 162 💬
87Panzyga----1件: 14 💬
88Paracetamolo----7件: 2, 11, 14, 28, 61, 63, 309 💬
89Peripheral blood stem cell transplantation----12件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
90Prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬38件: 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
91Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
92Prevenar 13 sospensione PER iniezione----1件: 14 💬
93Privigen1件: Human immunoglobulin G1件: Globulin, immune 💬 --5件: 11, 14, 51, 63, 65 💬
94Recombinant human hyaluronidase2件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--3件: 14, 28, 65 💬
95Rhuph20----2件: 13, 14 💬
96Riliprubart1件: Riliprubart1件: Riliprubart 💬 1件: C1S 💬 5件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 14 💬
97Ripertamab1件: Ripertamab---1件: 14 💬
98Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
99Rozanolixizumab1件: Rozanolixizumab1件: Rozanolixizumab 💬 --3件: 11, 14, 63 💬
100RVG 51680----1件: 14 💬
101RVG 56083----1件: 14 💬
102RVT-1401----3件: 11, 14, 61 💬
103SAR445088----2件: 14, 61 💬
104SC investigational needle sets----2件: 14, 65 💬
105Sodium chloride1件: Sodium chloride1件: Sodium chloride 💬 --20件: 2, 11, 13, 14, 34, 41, 46, 51, 53, 60, 67, 70, 96, 97, 193, 214, 215, 227, 288, 299 💬
106Soliris1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬6件: 11, 13, 14, 62, 109, 222 💬
107Solu medrol - 125 MG/2 ML polvere E solvente PER soluzione iniettabile 1 flacone A doppia camera DA 125 MG/2 ML----2件: 13, 14 💬
108Subcutaneous immune globulin G----1件: 14 💬
109Subcutaneous immunoglobulin----1件: 14 💬
110Subcuvia----3件: 14, 49, 65 💬
111Syngeneic bone marrow transplantation----3件: 11, 13, 14 💬
112TAK-411----1件: 14 💬
113TAK-771----2件: 14, 65 💬
114TAK-881----2件: 14, 65 💬
115Tetanus toxoid1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)2件: Tetanus toxoid adsorbed ,
Tetanus toxoid 💬 		--3件: 13, 14, 46 💬
116Trimeton - 10 MG/1 ML soluzione iniettabile 5 fiale 1 ML----1件: 14 💬
117UCB76651件: Rozanolixizumab1件: Rozanolixizumab 💬 --3件: 11, 14, 63 💬
118Vaccino pneumococcico saccaridico----1件: 14 💬
119Vivaglobin----2件: 14, 65 💬